AFP Expressing Tumors clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • AFPᶜ³³²T in Advanced HCC

    Sorry, in progress, not accepting new patients

    This first time in human study is intended for men and women between 18 and 75 years of age who have advanced liver cancer which has grown or returned after being treated or another AFP expressing tumor. Those who did not tolerate or refused other…

    Los Angeles, California and other locations

Our lead scientists for AFP Expressing Tumors research studies include .

Last updated: